The discrepant epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV)

Environment Systems and Decisions

Volumn 34, Issue 3, 2014, Pages 383-390

  MacIntyre, C Raina ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Bioterrorism; Emerging infectious disease; Epidemiology; MERS CoV

Indexed keywords

EID: 84939892672     PISSN: 21945403     EISSN: 21945411     Source Type: Journal    
DOI: 10.1007/s10669-014-9506-5     Document Type: Article

References (31)

1. Aburizaiza AS, Mattes FM, Azhar EI, Hassan AM, Memish ZA, Muth D et al (2014) Investigation of anti–MERS–Coronavirus antibodies in blood donors and abbatoir workers in Jeddah and Makkah, Kingdom of Saudi Arabia, Fall 2012. J Infect Dis 209:243–246
2. Airports Council International (2013) Preliminary 2012 world airport traffic and rankings. Available from: http://www.aci.aero
3. Anderson R, May R (2008) Infectious diseases of humans. Dynamics and control. Oxford University Press Inc., New York
4. Annan A, Baldwin H, Corman V, Klose S, Owusu M, Nkrumah EE et al (2013) Human betacoronavirus 2c EMC/2012–related viruses in bats, Ghana and Europe. Emerg Infect Dis 19(3):456–459
5. Assiri A, et al (2013) Hospital outbreak of Middle East respiratory syndrome coronavirus. New Engl J Med http://www.nejm.org/doi/pdf/10.1056/NEJMoa1306742
6. Breban R, Riou J, Fontanet A (2013) Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet http://ac.els-cdn.com/S0140673613614920/1-s2.0-S0140673613614920-main.pdf?_tid=7c7bd8ce-ecf3-11e2-a34f-00000aacb360&acdnat=1373854308_04bc4dc5863770b1711ff1ed88b0fdd0
7. Cauchemez S, Van Kerkhove MD, Riley S, Donnelly CA, Fraser C, Ferguson NM (2013) Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill 18(24):pii=20503
8. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A (2014) Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis 14:50–56
9. Centers for Disease Control and Prevention (2013) Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV)—worldwide, 2012–2013. MMWR Morb Mortal Wkly Rep 62:1–4
10. CONSISE (2013) Novel coronavirus (MERSCoV). The consortium for the standardization of influenza seroepidemiology (CONSISE) Steering Committee 2013; http://consise.tghn.org/articles/novel-coronavirus-ncov
11. Cotten M, Lam T, Watson SJ, Palser AL, Petrova V, Grant P, et al (2013a) Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus. Emerg Infect Dis. doi:10.3201/eid1905.130057
12. Cotten M et al (2013b) Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 382:1993–2002
13. Drosten C, Seilmaier M, Corman V, Hartmann W, Scheible G, Sack S, Guggemos W et al (2013) Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 13:745–751
14. Gardner L et al (2014) A scenario-based evaluation of the Middle East respiratory syndrome coronavirus and the Hajj. Risk Anal. doi:10.1111/risa.12253
15. Gautret P et al (2013) Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect 19(7):E315–E317
16. Group TWM-CR (2013) State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERSCoV) in humans. PLOS Current Outbreaks
17. Ithete NL, Stoffberg S, Corman VM, Cottontail VM, Richards LR et al (2013) Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis 19:1697–1699
18. Joseph C et al (2013) Highlights and conclusions from the technical consultative meeting on novel coronavirus infection, Cairo, Egypt, 14–16 January 2013. East Mediterr Health J 19(Suppl 1):S68–S74
19. Memish ZA, et al (2014) Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin Microbiol Infect. doi:10.1111/1469-0691.12562
20. Memish Z, Rabeeah A (2012) Health conditions for travellers to Saudi Arabia for the Umrah and Hajj pilgrimage to Mecca: requirements for 2012 (1433). J Infect Public Health 5(2):113–115
21. Meyer B, Müller MA, Corman VM, Reusken CB, Ritz D, Godeke G-D et al (2014) Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis 20(4):552–559
22. Nicoll A (2013) Public health investigations required for protecting the population against novel coronaviruses. Eastern Mediterranean Health Journal
23. Palm D, et al (2012) Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012. Euro Surveill 17(49):pii=20335. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20335
24. Perera R, Wang P, Gomaa M, El-Shesheny R, Kandeil A, Bagato O et al (2013) Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt. Euro Surveill 18(36):pii=20574
25. Perl T, McGeer A, Price C (2014) Medusa’s ugly head again: from SARS to MERS-CoV. Ann Intern Med 160(6):p432
26. Reusken CB, Haagmans BL, Müller MA, Gutierrez C, Godeke GJ, Meyer B et al (2013a) Middle East respiratory syndrome coronavirus neutralizing serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13:859–866
27. Reusken C, Mou H, Godeke GJ, van der Hoek L, Meyer B, Müller MA et al (2013b) Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill 18(14): pii=20441
28. Uyeki T (2008) Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. Respirology 13:S2–S9
29. Wallinga J, Teunis P (2004) Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am J Epidemiol 160(6):509–516
30. World Health Organization (2013) Background and summary of novel coronavirus infection—as of 22 November 2013. http://www.who.int/csr/disease/coronavirus_infections/Update12_MERSCoV_update_22Nov13.pdf
31. World Health Organization. Global alert and response (GAR): pandemic and epidemic diseases (http://www.who.int/csr/disease/en/)